Copyright
©The Author(s) 2019.
World J Diabetes. Feb 15, 2019; 10(2): 96-113
Published online Feb 15, 2019. doi: 10.4239/wjd.v10.i2.96
Published online Feb 15, 2019. doi: 10.4239/wjd.v10.i2.96
Ref. | Study design | Subjects | Treatment | Outcome measures | Effectiveness |
Khoshpey et al[12] | Randomized double-blind controlled trial | N = 11 females + 12 males aged 20-65 with type 2 diabetes in control group (placebo) | 3000 mg royal jelly oral capsules once per day for 8 wk. Control received placebo | Macronutrient intake | No significant change in macronutrient intake |
N = 13 females + 10 males aged 20-65 with type 2 diabetes in treatment group | Hyperglycemia: Fasting blood glucose | Fasting blood glucose significantly reduced in comparison to control group (d = -0.87) | |||
Mobasseri et al[28] | Randomized controlled trial | N = 25 + 25 females with type 2 diabetes aged 30-65 in control and treatment groups | 200 mg royal jelly powder prepared in gel form and served with breakfast for 8 wk. Control group received placebo | Plasma triglyceride | Significantly decreased plasma triglyceride in comparison to control (d = -0.476) |
Morita et al[29] | Randomized double-blind controlled trial | N = 30 healthy adults 42-83 yr of age in control (placebo) | 3000 mg royal jelly in 100 mL liquid daily for 6 mo. Control received placebo identical in appearance | Body weight: BMI | Significantly improved fasting blood glucose (d = -0.9596) |
N = 31 healthy adults 42-83 yr of age in treatment group | Insulin resistance: HOMA-IR | No significant changes in other outcomes of interest | |||
Hyperglycemia: HbA1c, fasting blood glucose | |||||
Plasma triglyceride | |||||
Pourmoradian et al[13] | Human double-blinded randomized clinical trial | N = 23 females aged 30-65 with type 2 diabetes in treatment group | 1000 mg lyophilized royal jelly in soft gel form served after breakfast for 8 wk. Control group received placebo soft gel | Body weight: weight scale before and after study period | Significantly decreased body weight within same group, before and after intervention (d = -0.3808) |
N = 22 females aged 30-65 with type 2 diabetes in control group | Macronutrient intake: 24-h recall food questionnaire for 3 d before and after study period | Significantly decreased energy intake within same group, before and after intervention (d = -9.52) | |||
Pourmoradian et al[30] | Human double-blinded randomized controlled trial | N = 21 females aged 30-65 with type 2 diabetes in treatment group | 1000 mg lyophilized royal jelly in soft gel form served after breakfast for 8 wk. Control group received placebo soft gel | Plasma insulin | Significantly decreased plasma insulin and HbA1c and insignificantly decreased fasting blood glucose compared to baseline within same group, before and after intervention. |
N = 20 females aged 30-65 with type 2 diabetes in control group | HbA1c | d = 0.016 (HbA1c) | |||
Hyperglycemia: Fasting blood glucose | d = -0.0785 (plasma insulin) | ||||
Shidfar et al[31] | Human double-blinded randomized controlled trial | N = 23 + 23 adults 25-65 yr old with type 2 diabetes in experimental and control (placebo) groups | 1000 mg royal jelly in soft gelatin capsules 3 times daily for 8 wk. Control group received placebo identical in appearance to treatment | Fasting blood sugar | Significantly decreased fasting blood levels to more normal range (d = -0.3725) |
Macronutrient intake: 24-h recall diet questionnaire | Did not significantly alter macronutrient intake | ||||
Insulin resistance: HOMA-IR | Significantly decreased HOMA-IR: improved insulin sensitivity (d = -0.79) |
- Citation: Omer K, Gelkopf MJ, Newton G. Effectiveness of royal jelly supplementation in glycemic regulation: A systematic review. World J Diabetes 2019; 10(2): 96-113
- URL: https://www.wjgnet.com/1948-9358/full/v10/i2/96.htm
- DOI: https://dx.doi.org/10.4239/wjd.v10.i2.96